Anrotinib Hydrochloride Combined With Adriamycin for Neoadjuvant Treatment of High-grade Soft Tissue Sarcoma
Clinical trial NCT05747521 · UNKNOWN
Trial details
- NCT number
- NCT05747521
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-29
- Primary completion
- 2024-09-30
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.